 | • レポートコード：20QY06-07379 • 出版社/出版日：QYResearch / 2020年6月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、137ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、注射用抗凝固剤のグローバル市場について種類別（低分子ヘパリン（LMWH）、直接トロンビン阻害剤（DTI）、その他）、用途別（VTE、ACS/MI、AF、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・注射用抗凝固剤市場の概要 ・世界の主要地域別注射用抗凝固剤市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の注射用抗凝固剤市場規模2015-2026：種類別（低分子ヘパリン（LMWH）、直接トロンビン阻害剤（DTI）、その他） ・世界の注射用抗凝固剤市場規模2015-2026：用途別（VTE、ACS/MI、AF、その他） ・注射用抗凝固剤の北米市場規模2015-2020 ・注射用抗凝固剤のヨーロッパ市場規模2015-2020 ・注射用抗凝固剤の中国市場規模2015-2020 ・注射用抗凝固剤の日本市場規模2015-2020 ・注射用抗凝固剤の東南アジア市場規模2015-2020 ・注射用抗凝固剤のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Sanofi、Genentech (Roche)、Boehringer Ingelheim、Pfizer、The Medicines Company、Aspen、Otsuka） ・注射用抗凝固剤の製造コスト分析 ・販売チャネル、流通業者、顧客 ・注射用抗凝固剤の市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Injectable Anticoagulants Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Injectable Anticoagulants market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
The injectable anticoagulants include low molecular weight heparin (LMWH) agents (dalteparin [Fragmin®], enoxaparin [Lovenox®]) and factor Xa inhibitors (fondaparinux [Arixtra®]).
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Injectable Anticoagulants market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Injectable Anticoagulants industry.
Based on our recent survey, we have several different scenarios about the Injectable Anticoagulants YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 5814.9 million in 2019. The market size of Injectable Anticoagulants will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Injectable Anticoagulants market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Injectable Anticoagulants market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Injectable Anticoagulants market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Injectable Anticoagulants market. The report also includes nautical information, where it shows Injectable Anticoagulants market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Injectable Anticoagulants market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Injectable Anticoagulants market.
In the last several years, global market of injectable anticoagulants developed slowly. In 2016, global revenue of injectable anticoagulants is nearly 5300 M USD. And the global growth rate is slow.
Geographical Analysis:
Based on region, the global Injectable Anticoagulants market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Injectable Anticoagulants market are
Sanofi
Genentech (Roche)
Boehringer Ingelheim
Pfizer
The Medicines Company
Aspen
Otsuka
…
Segment by Type
Low-molecular-weight Heparin (LMWH)
Direct Thrombin Inhibitor (DTI)
Other
Segment by Application
VTE
ACS/MI
AF
Other
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Injectable Anticoagulants market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Injectable Anticoagulants market.
• The market share of the global Injectable Anticoagulants market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Injectable Anticoagulants market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Injectable Anticoagulants market.
1 Injectable Anticoagulants Market Overview
1.1 Injectable Anticoagulants Product Scope
1.2 Injectable Anticoagulants Segment by Type
1.2.1 Global Injectable Anticoagulants Sales by Type (2020-2026)
1.2.2 Low-molecular-weight Heparin (LMWH)
1.2.3 Direct Thrombin Inhibitor (DTI)
1.2.4 Other
1.3 Injectable Anticoagulants Segment by Application
1.3.1 Global Injectable Anticoagulants Sales Comparison by Application (2020-2026)
1.3.2 VTE
1.3.3 ACS/MI
1.3.4 AF
1.3.5 Other
1.4 Injectable Anticoagulants Market Estimates and Forecasts (2015-2026)
1.4.1 Global Injectable Anticoagulants Sales Growth Rate (2015-2026)
1.4.2 Global Injectable Anticoagulants Revenue and Growth Rate (2015-2026)
1.4.3 Global Injectable Anticoagulants Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Injectable Anticoagulants Industry Impact
1.5.1 How the Covid-19 is Affecting the Injectable Anticoagulants Industry
1.5.1.1 Injectable Anticoagulants Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Injectable Anticoagulants Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Injectable Anticoagulants Players to Combat Covid-19 Impact
2 Injectable Anticoagulants Estimate and Forecast by Region
2.1 Global Injectable Anticoagulants Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Injectable Anticoagulants Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Injectable Anticoagulants Sales Market Share by Region (2015-2020)
2.2.2 Global Injectable Anticoagulants Revenue Market Share by Region (2015-2020)
2.3 Global Injectable Anticoagulants Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Injectable Anticoagulants Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Injectable Anticoagulants Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Injectable Anticoagulants Estimates and Projections (2015-2026)
2.4.2 Europe Injectable Anticoagulants Estimates and Projections (2015-2026)
2.4.3 China Injectable Anticoagulants Estimates and Projections (2015-2026)
2.4.4 Japan Injectable Anticoagulants Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Injectable Anticoagulants Estimates and Projections (2015-2026)
2.4.6 India Injectable Anticoagulants Estimates and Projections (2015-2026)
3 Global Injectable Anticoagulants Competition Landscape by Players
3.1 Global Top Injectable Anticoagulants Players by Sales (2015-2020)
3.2 Global Top Injectable Anticoagulants Players by Revenue (2015-2020)
3.3 Global Injectable Anticoagulants Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Injectable Anticoagulants as of 2019)
3.4 Global Injectable Anticoagulants Average Price by Company (2015-2020)
3.5 Manufacturers Injectable Anticoagulants Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Injectable Anticoagulants Players (Opinion Leaders)
4 Global Injectable Anticoagulants Market Size by Type
4.1 Global Injectable Anticoagulants Historic Market Review by Type (2015-2020)
4.1.1 Global Injectable Anticoagulants Sales Market Share by Type (2015-2020)
4.1.2 Global Injectable Anticoagulants Revenue Market Share by Type (2015-2020)
4.1.3 Global Injectable Anticoagulants Price by Type (2014-2020)
4.2 Global Injectable Anticoagulants Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Injectable Anticoagulants Sales Forecast by Type (2021-2026)
4.2.2 Global Injectable Anticoagulants Revenue Forecast by Type (2021-2026)
4.2.3 Global Injectable Anticoagulants Price Forecast by Type (2021-2026)
5 Global Injectable Anticoagulants Market Size by Application
5.1 Global Injectable Anticoagulants Historic Market Review by Application (2015-2020)
5.1.1 Global Injectable Anticoagulants Sales Market Share by Application (2015-2020)
5.1.2 Global Injectable Anticoagulants Revenue Market Share by Application (2015-2020)
5.1.3 Global Injectable Anticoagulants Price by Application (2015-2020)
5.2 Global Injectable Anticoagulants Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Injectable Anticoagulants Sales Forecast by Application (2021-2026)
5.2.2 Global Injectable Anticoagulants Revenue Forecast by Application (2021-2026)
5.2.3 Global Injectable Anticoagulants Price Forecast by Application (2021-2026)
3 North America Injectable Anticoagulants Market Facts & Figures
3.2 North America Injectable Anticoagulants Sales Market Share by Company (2015-2020)
3.3 North America Injectable Anticoagulants Sales Market Share by Type (2015-2020)
3.4 North America Injectable Anticoagulants Sales Market Share by Application (2015-2020)
4 Europe Injectable Anticoagulants Market Facts & Figures
4.2 Europe Injectable Anticoagulants Sales Market Share by Company (2015-2020)
4.3 Europe Injectable Anticoagulants Sales Market Share by Type (2015-2020)
4.4 Europe Injectable Anticoagulants Sales Market Share by Application (2015-2020)
5 China Injectable Anticoagulants Market Facts & Figures
5.2 China Injectable Anticoagulants Sales Market Share by Company (2015-2020)
5.3 China Injectable Anticoagulants Sales Market Share by Type (2015-2020)
5.4 China Injectable Anticoagulants Sales Market Share by Application (2015-2020)
6 Japan Injectable Anticoagulants Market Facts & Figures
6.2 Japan Injectable Anticoagulants Sales Market Share by Company (2015-2020)
6.3 Japan Injectable Anticoagulants Sales Market Share by Type (2015-2020)
6.4 Japan Injectable Anticoagulants Sales Market Share by Application (2015-2020)
7 Southeast Asia Injectable Anticoagulants Market Facts & Figures
7.2 Southeast Asia Injectable Anticoagulants Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Injectable Anticoagulants Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Injectable Anticoagulants Sales Market Share by Application (2015-2020)
8 India Injectable Anticoagulants Market Facts & Figures
8.2 India Injectable Anticoagulants Sales Market Share by Company (2015-2020)
8.3 India Injectable Anticoagulants Sales Market Share by Type (2015-2020)
8.4 India Injectable Anticoagulants Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Injectable Anticoagulants Business
12.1 Sanofi
12.1.1 Sanofi Injectable Anticoagulants Corporation Information
12.1.2 Sanofi Injectable Anticoagulants Business Overview and Total Revenue
12.1.3 Sanofi Injectable Anticoagulants Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Sanofi Injectable Anticoagulants Products Offered
12.1.5 Sanofi Recent Development
12.2 Genentech (Roche)
12.2.1 Genentech (Roche) Injectable Anticoagulants Corporation Information
12.2.2 Genentech (Roche) Injectable Anticoagulants Business Overview and Total Revenue
12.2.3 Genentech (Roche) Injectable Anticoagulants Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Genentech (Roche) Injectable Anticoagulants Products Offered
12.2.5 Genentech (Roche) Recent Development
12.3 Boehringer Ingelheim
12.3.1 Boehringer Ingelheim Injectable Anticoagulants Corporation Information
12.3.2 Boehringer Ingelheim Injectable Anticoagulants Business Overview and Total Revenue
12.3.3 Boehringer Ingelheim Injectable Anticoagulants Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Boehringer Ingelheim Injectable Anticoagulants Products Offered
12.3.5 Boehringer Ingelheim Recent Development
12.4 Pfizer
12.4.1 Pfizer Injectable Anticoagulants Corporation Information
12.4.2 Pfizer Injectable Anticoagulants Business Overview and Total Revenue
12.4.3 Pfizer Injectable Anticoagulants Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Pfizer Injectable Anticoagulants Products Offered
12.4.5 Pfizer Recent Development
12.5 The Medicines Company
12.5.1 The Medicines Company Injectable Anticoagulants Corporation Information
12.5.2 The Medicines Company Injectable Anticoagulants Business Overview and Total Revenue
12.5.3 The Medicines Company Injectable Anticoagulants Sales, Revenue and Gross Margin (2015-2020)
12.5.4 The Medicines Company Injectable Anticoagulants Products Offered
12.5.5 The Medicines Company Recent Development
12.6 Aspen
12.6.1 Aspen Injectable Anticoagulants Corporation Information
12.6.2 Aspen Injectable Anticoagulants Business Overview and Total Revenue
12.6.3 Aspen Injectable Anticoagulants Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Aspen Injectable Anticoagulants Products Offered
12.6.5 Aspen Recent Development
12.7 Otsuka
12.7.1 Otsuka Injectable Anticoagulants Corporation Information
12.7.2 Otsuka Injectable Anticoagulants Business Overview and Total Revenue
12.7.3 Otsuka Injectable Anticoagulants Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Otsuka Injectable Anticoagulants Products Offered
12.7.5 Otsuka Recent Development
…
13 Injectable Anticoagulants Manufacturing Cost Analysis
13.1 Injectable Anticoagulants Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Injectable Anticoagulants
13.4 Injectable Anticoagulants Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Injectable Anticoagulants Distributors List
14.3 Injectable Anticoagulants Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Injectable Anticoagulants Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Injectable Anticoagulants Sales (K Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Injectable Anticoagulants Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Injectable Anticoagulants Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Injectable Anticoagulants Players to Combat Covid-19 Impact
Table 8. Global Market Injectable Anticoagulants Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Injectable Anticoagulants Sales (K Units) by Region (2015-2020)
Table 10. Global Injectable Anticoagulants Sales Market Share by Region (2015-2020)
Table 11. Global Injectable Anticoagulants Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Injectable Anticoagulants Revenue Share by Region (2015-2020)
Table 13. Global Injectable Anticoagulants Sales (K Units) Forecast by Region (2021-2026)
Table 14. Global Injectable Anticoagulants Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Injectable Anticoagulants Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Injectable Anticoagulants Revenue Share Forecast by Region (2021-2026)
Table 17. Global Injectable Anticoagulants (K Units) of Key Companies (2015-2020)
Table 18. Global Injectable Anticoagulants Sales Share by Company (2015-2020)
Table 19. Global Injectable Anticoagulants Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Injectable Anticoagulants Revenue Share by Company (2015-2020)
Table 21. Global Injectable Anticoagulants by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Injectable Anticoagulants as of 2019)
Table 22. Global Injectable Anticoagulants Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Injectable Anticoagulants Manufacturing Sites and Area Served
Table 24. Manufacturers Injectable Anticoagulants Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Injectable Anticoagulants Players
Table 27. Global Injectable Anticoagulants Sales (K Units) by Type (2015-2020)
Table 28. Global Injectable Anticoagulants Sales Share by Type (2015-2020)
Table 29. Global Injectable Anticoagulants Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Injectable Anticoagulants Price (K Units) by Type (2015-2020)
Table 31. Global Injectable Anticoagulants Sales Share by Type (2021-2026)
Table 32. Global Injectable Anticoagulants Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Injectable Anticoagulants Revenue Share by Type (2021-2026)
Table 34. Global Injectable Anticoagulants Price (K Units) by Type (2021-2026)
Table 35. Global Injectable Anticoagulants Sales (K Units) by Application (2015-2020)
Table 36. Global Injectable Anticoagulants Sales Share by Application (2015-2020)
Table 37. Global Injectable Anticoagulants Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Injectable Anticoagulants Price (K Units) by Application (2015-2020)
Table 39. Global Injectable Anticoagulants Sales (K Units) by Application (2021-2026)
Table 40. Global Injectable Anticoagulants Sales Share by Application (2021-2026)
Table 41. Global Injectable Anticoagulants Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Injectable Anticoagulants Revenue Share by Application (2021-2026)
Table 43. Global Injectable Anticoagulants Price (K Units) by Application (2021-2026)
Table 44. United States Injectable Anticoagulants Sales (K Units) by Company (2015-2020)
Table 45. United States Injectable Anticoagulants Sales Market Share by Company (2015-2020)
Table 46. United States Injectable Anticoagulants Sales (K Units) by Type (2015-2020)
Table 47. United States Injectable Anticoagulants Sales Market Share by Type (2015-2020)
Table 48. United States Injectable Anticoagulants Sales (K Units) by Application (2015-2020)
Table 49. United States Injectable Anticoagulants Sales Market Share by Application (2015-2020)
Table 50. Europe Injectable Anticoagulants Sales (K Units) by Company (2015-2020)
Table 51. Europe Injectable Anticoagulants Sales Market Share by Company (2015-2020)
Table 52. Europe Injectable Anticoagulants Sales (K Units) by Type (2015-2020)
Table 53. Europe Injectable Anticoagulants Sales Market Share by Type (2015-2020)
Table 54. Europe Injectable Anticoagulants Sales (K Units) by Application (2015-2020)
Table 55. Europe Injectable Anticoagulants Sales Market Share by Type (2015-2020)
Table 56. China Injectable Anticoagulants Sales (K Units) by Company (2015-2020)
Table 57. China Injectable Anticoagulants Sales Market Share by Company (2015-2020)
Table 58. China Injectable Anticoagulants Sales (K Units) by Type (2015-2020)
Table 59. China Injectable Anticoagulants Sales Market Share by Type (2015-2020)
Table 60. China Injectable Anticoagulants Sales (K Units) by Application (2015-2020)
Table 61. China Injectable Anticoagulants Sales Market Share by Application (2015-2020)
Table 62. Japan Injectable Anticoagulants Sales (K Units) by Company (2015-2020)
Table 63. Japan Injectable Anticoagulants Sales Market Share by Company (2015-2020)
Table 64. Japan Injectable Anticoagulants Sales (K Units) by Type (2015-2020)
Table 65. Japan Injectable Anticoagulants Sales Market Share by Type (2015-2020)
Table 66. Japan Injectable Anticoagulants Sales (K Units) by Application (2015-2020)
Table 67. Japan Injectable Anticoagulants Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Injectable Anticoagulants Sales (K Units) by Company (2015-2020)
Table 69. Southeast Asia Injectable Anticoagulants Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Injectable Anticoagulants Sales (K Units) by Type (2015-2020)
Table 71. Southeast Asia Injectable Anticoagulants Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Injectable Anticoagulants Sales (K Units) by Type (2015-2020)
Table 73. Southeast Asia Injectable Anticoagulants Sales Market Share by Application (2015-2020)
Table 74. India Injectable Anticoagulants Sales (K Units) by Company (2015-2020)
Table 75. India Injectable Anticoagulants Sales Market Share by Company (2015-2020)
Table 76. India Injectable Anticoagulants Sales (K Units) by Type (2015-2020)
Table 77. India Injectable Anticoagulants Sales Market Share by Type (2015-2020)
Table 78. India Injectable Anticoagulants Sales (K Units) by Application (2015-2020)
Table 79. India Injectable Anticoagulants Sales Market Share by Application (2015-2020)
Table 80. Sanofi Corporation Information
Table 81. Sanofi Description and Business Overview
Table 82. Sanofi Injectable Anticoagulants Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Sanofi Injectable Anticoagulants Product
Table 84. Sanofi Recent Development
Table 85. Genentech (Roche) Corporation Information
Table 86. Genentech (Roche) Description and Business Overview
Table 87. Genentech (Roche) Injectable Anticoagulants Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Genentech (Roche) Injectable Anticoagulants Product
Table 89. Genentech (Roche) Recent Development
Table 90. Boehringer Ingelheim Corporation Information
Table 91. Boehringer Ingelheim Description and Business Overview
Table 92. Boehringer Ingelheim Injectable Anticoagulants Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Boehringer Ingelheim Injectable Anticoagulants Product
Table 94. Boehringer Ingelheim Recent Development
Table 95. Pfizer Corporation Information
Table 96. Pfizer Description and Business Overview
Table 97. Pfizer Injectable Anticoagulants Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Pfizer Injectable Anticoagulants Product
Table 99. Pfizer Recent Development
Table 100. The Medicines Company Corporation Information
Table 101. The Medicines Company Description and Business Overview
Table 102. The Medicines Company Injectable Anticoagulants Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. The Medicines Company Injectable Anticoagulants Product
Table 104. The Medicines Company Recent Development
Table 105. Aspen Corporation Information
Table 106. Aspen Description and Business Overview
Table 107. Aspen Injectable Anticoagulants Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Aspen Injectable Anticoagulants Product
Table 109. Aspen Recent Development
Table . Otsuka Corporation Information
Table . Otsuka Description and Business Overview
Table . Otsuka Injectable Anticoagulants Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . Otsuka Injectable Anticoagulants Product
Table . Otsuka Recent Development
Table 115. Production Base and Market Concentration Rate of Raw Material
Table 116. Key Suppliers of Raw Materials
Table 117. Injectable Anticoagulants Distributors List
Table 118. Injectable Anticoagulants Customers List
Table 119. Market Key Trends
Table 120. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 121. Key Challenges
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Injectable Anticoagulants Product Picture
Figure 2. Global Injectable Anticoagulants Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Injectable Anticoagulants Market Share by Application in 2020 & 2026
Figure 6. VTE Examples
Figure 7. ACS/MI Examples
Figure 8. AF Examples
Figure 9. Other Examples
Figure 10. Global Injectable Anticoagulants Sales (K Units) Growth Rate (2015-2026)
Figure 11. Global Injectable Anticoagulants Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global Injectable Anticoagulants Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 13. Global Injectable Anticoagulants Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global Injectable Anticoagulants Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States Injectable Anticoagulants Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States Injectable Anticoagulants Sales (K Units) Growth Rate (2015-2026)
Figure 17. Europe Injectable Anticoagulants Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe Injectable Anticoagulants Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China Injectable Anticoagulants Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China Injectable Anticoagulants Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan Injectable Anticoagulants Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan Injectable Anticoagulants Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Injectable Anticoagulants Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Injectable Anticoagulants Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India Injectable Anticoagulants Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India Injectable Anticoagulants Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest Injectable Anticoagulants Players Market Share by Revenue in Injectable Anticoagulants 2015 & 2019
Figure 28. Injectable Anticoagulants Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Injectable Anticoagulants Revenue Share by Type (2015-2020)
Figure 30. Global Injectable Anticoagulants Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global Injectable Anticoagulants Revenue Share by Application (2015-2020)
Figure 32. Global Injectable Anticoagulants Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States Injectable Anticoagulants Sales Market Share by Type in 2019
Figure 34. United States Injectable Anticoagulants Sales Market Share by Type in 2019
Figure 35. Europe Injectable Anticoagulants Sales Market Share by Company in 2019
Figure 36. Europe Injectable Anticoagulants Sales Market Share by Type in 2019
Figure 37. Europe Injectable Anticoagulants Sales Market Share by Application in 2019
Figure 38. China Injectable Anticoagulants Sales Market Share by Company in 2019
Figure 39. China Injectable Anticoagulants Sales Market Share by Type in 2019
Figure 40. China Injectable Anticoagulants Sales Market Share by Application in 2019
Figure 41. Japan Injectable Anticoagulants Sales Market Share by Company in 2019
Figure 42. Japan Injectable Anticoagulants Sales Market Share by Type in 2019
Figure 43. Japan Injectable Anticoagulants Sales Market Share by Application in 2019
Figure 44. Southeast Asia Injectable Anticoagulants Sales Market Share by Company in 2019
Figure 45. Southeast Asia Injectable Anticoagulants Sales Market Share by Type in 2019
Figure 46. Southeast Asia Injectable Anticoagulants Sales Market Share by Application in 2019
Figure 47. India Injectable Anticoagulants Sales Market Share by Company in 2019
Figure 48. India Injectable Anticoagulants Sales Market Share by Type in 2019
Figure 49. India Injectable Anticoagulants Sales Market Share by Application in 2019
Figure 50. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Genentech (Roche) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. The Medicines Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Aspen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Otsuka Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Key Raw Materials Price Trend
Figure 58. Manufacturing Cost Structure of Injectable Anticoagulants
Figure 59. Manufacturing Process Analysis of Injectable Anticoagulants
Figure 60. Injectable Anticoagulants Industrial Chain Analysis
Figure 61. Channels of Distribution
Figure 62. Distributors Profiles
Figure 63. Porter's Five Forces Analysis
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
抗凝固剤の世界市場レポート2020 A recently published report by QY Research titled Global Anticoagulants Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate dat…- 注射可能型ドラッグデリバリーデバイスの世界市場レポート2020 Injectable drug delivery devices are the devices used to administer drugs into the circulatory system. It is the most effective and common route for the administration of most therapeutic agents to ensure a quick response. Injectable drugs are used when patient is unconscious and require quick effec…
- 無菌注射薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Sterile Injectable Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.0% in the forecast period of 2020 to 2025 and will expected to reach USD 4258.5 million by 2025, from USD 3506.7 million in 2019. The Sterile Inj…
- ジェネリック腫瘍滅菌注射の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Generic Oncology Sterile Injectable market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.2% in the forecast period of 2020 to 2025 and will expected to reach USD 12600 million by 2025, from USD 9912.3 million in 2019. The G…
- 一般無菌注射の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Generic Sterile Injectable market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.5% in the forecast period of 2020 to 2025 and will expected to reach USD 63660 million by 2025, from USD 51320 million in 2019. The Generic Ste…